IDEAS home Printed from https://ideas.repec.org/a/spr/hecrev/v4y2014i1p1-1610.1186-s13561-014-0018-2.html
   My bibliography  Save this article

Modeling rheumatoid arthritis using different techniques - a review of model construction and results

Author

Listed:
  • Stefan Scholz
  • Thomas Mittendorf

Abstract

Given a sufficient data supply, DES is the modeling technique of choice when modeling cost-effectiveness in RA. Otherwise transparency on the data inputs is crucial for valid results and to inform decision makers about possible biases. With regard to ICERs, Markov models might provide similar estimates as more advanced modeling techniques. Copyright Scholz and Mittendorf; licensee Springer. 2014

Suggested Citation

  • Stefan Scholz & Thomas Mittendorf, 2014. "Modeling rheumatoid arthritis using different techniques - a review of model construction and results," Health Economics Review, Springer, vol. 4(1), pages 1-16, December.
    • Handle: RePEc:spr:hecrev:v:4:y:2014:i:1:p:1-16:10.1186/s13561-014-0018-2
    DOI: 10.1186/s13561-014-0018-2
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1186/s13561-014-0018-2
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.1186/s13561-014-0018-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Sonja Merkesdal & Timm Kirchhoff & Diane Wolka & Gunter Ladinek & Adrian Kielhorn & Andrea Rubbert-Roth, 2010. "Cost-effectiveness analysis of rituximab treatment in patients in Germany with rheumatoid arthritis after etanercept-failure," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 11(1), pages 95-104, February.
    2. Christine Nguyen & Mark Bounthavong & Margaret Mendes & Melissa Christopher & Josephine Tran & Rashid Kazerooni & Anthony Morreale, 2012. "Cost Utility of Tumour Necrosis Factor-α Inhibitors for Rheumatoid Arthritis," PharmacoEconomics, Springer, vol. 30(7), pages 575-593, July.
    3. Jonathan Karnon & James Stahl & Alan Brennan & J. Jaime Caro & Javier Mar & Jörgen Möller, 2012. "Modeling Using Discrete Event Simulation," Medical Decision Making, , vol. 32(5), pages 701-711, September.
    4. Janneke Grutters & Mark Sculpher & Andrew Briggs & Johan Severens & Math Candel & James Stahl & Dirk Ruysscher & Albert Boer & Bram Ramaekers & Manuela Joore, 2013. "Acknowledging Patient Heterogeneity in Economic Evaluation," PharmacoEconomics, Springer, vol. 31(2), pages 111-123, February.
    5. Bin Wu & Alisa Wilson & Fang-fang Wang & Su-li Wang & Daniel J Wallace & Michael H Weisman & Liang-jing Lu, 2012. "Cost Effectiveness of Different Treatment Strategies in the Treatment of Patients with Moderate to Severe Rheumatoid Arthritis in China," PLOS ONE, Public Library of Science, vol. 7(10), pages 1-11, October.
    6. James Spalding & Joel Hay, 2006. "Cost Effectiveness of Tumour Necrosis Factor-α Inhibitors as First-Line Agents in Rheumatoid Arthritis," PharmacoEconomics, Springer, vol. 24(12), pages 1221-1232, December.
    7. Kit Simpson & Alvin Strassburger & Walter Jones & Birgitta Dietz & Rukmini Rajagopalan, 2009. "Comparison of Markov Model and Discrete-Event Simulation Techniques for HIV," PharmacoEconomics, Springer, vol. 27(2), pages 159-165, February.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Evo Alemao & Maiwenn J Al & Annelies A Boonen & Matthew D Stevenson & Suzanne M M Verstappen & Kaleb Michaud & Michael E Weinblatt & Maureen P M H Rutten-van Mölken, 2018. "Conceptual model for the health technology assessment of current and novel interventions in rheumatoid arthritis," PLOS ONE, Public Library of Science, vol. 13(10), pages 1-18, October.
    2. Mohammad Reza Davahli & Waldemar Karwowski & Redha Taiar, 2020. "A System Dynamics Simulation Applied to Healthcare: A Systematic Review," IJERPH, MDPI, vol. 17(16), pages 1-27, August.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Jaana T Joensuu & Saara Huoponen & Kalle J Aaltonen & Yrjö T Konttinen & Dan Nordström & Marja Blom, 2015. "The Cost-Effectiveness of Biologics for the Treatment of Rheumatoid Arthritis: A Systematic Review," PLOS ONE, Public Library of Science, vol. 10(3), pages 1-27, March.
    2. Hussain Abdulrahman Al-Omar & Hadeel Magdy Sherif & Ahmed Yaccob Mayet, 2019. "Vaccination status of patients using anti-TNF therapy and the physicians’ behavior shaping the phenomenon: Mixed-methods approach," PLOS ONE, Public Library of Science, vol. 14(10), pages 1-15, October.
    3. Evo Alemao & Maiwenn J Al & Annelies A Boonen & Matthew D Stevenson & Suzanne M M Verstappen & Kaleb Michaud & Michael E Weinblatt & Maureen P M H Rutten-van Mölken, 2018. "Conceptual model for the health technology assessment of current and novel interventions in rheumatoid arthritis," PLOS ONE, Public Library of Science, vol. 13(10), pages 1-18, October.
    4. Krol, Marieke & Brouwer, Werner, 2015. "Unpaid work in health economic evaluations," Social Science & Medicine, Elsevier, vol. 144(C), pages 127-137.
    5. Qi Cao & Erik Buskens & Hans L. Hillege & Tiny Jaarsma & Maarten Postma & Douwe Postmus, 2019. "Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(3), pages 475-482, April.
    6. Louise Freebairn & Jo-An Atkinson & Nathaniel D Osgood & Paul M Kelly & Geoff McDonnell & Lucie Rychetnik, 2019. "Turning conceptual systems maps into dynamic simulation models: An Australian case study for diabetes in pregnancy," PLOS ONE, Public Library of Science, vol. 14(6), pages 1-27, June.
    7. Xiuxian Wang & Na Geng & Jianxin Qiu & Zhibin Jiang & Liping Zhou, 2020. "Markov model and meta-heuristics combined method for cost-effectiveness analysis," Flexible Services and Manufacturing Journal, Springer, vol. 32(1), pages 213-235, March.
    8. Simone A. Huygens & Isaac Corro Ramos & Carlijn V. C. Bouten & Jolanda Kluin & Shih Ting Chiu & Gary L. Grunkemeier & Johanna J. M. Takkenberg & Maureen P. M. H. Rutten-van Mölken, 2020. "Early cost-utility analysis of tissue-engineered heart valves compared to bioprostheses in the aortic position in elderly patients," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(4), pages 557-572, June.
    9. Mark Bounthavong & Christine Nguyen & Margaret Mendes & Melissa Christopher & Josephine Tran & Rashid Kazerooni & Anthony Morreale, 2012. "The Authors’ Reply," PharmacoEconomics, Springer, vol. 30(10), pages 977-978, October.
    10. David Epstein & Leticia García-Mochón & Stephen Kaptoge & Simon G. Thompson, 2016. "Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(8), pages 1041-1053, November.
    11. Vojtěch Kamenský & Vladimír Rogalewicz & Ondřej Gajdoš & Gleb Donin, 2022. "Discrete Event Simulation Model for Cost-Effectiveness Evaluation of Screening for Asymptomatic Patients with Lower Extremity Arterial Disease," IJERPH, MDPI, vol. 19(18), pages 1-16, September.
    12. Alice Rondini & Fabiana Tornese & Maria Grazia Gnoni & Giuditta Pezzotta & Roberto Pinto, 2017. "Hybrid simulation modelling as a supporting tool for sustainable product service systems: a critical analysis," International Journal of Production Research, Taylor & Francis Journals, vol. 55(23), pages 6932-6945, December.
    13. Beate Jahn & Sarah Friedrich & Joachim Behnke & Joachim Engel & Ursula Garczarek & Ralf Münnich & Markus Pauly & Adalbert Wilhelm & Olaf Wolkenhauer & Markus Zwick & Uwe Siebert & Tim Friede, 2022. "On the role of data, statistics and decisions in a pandemic," AStA Advances in Statistical Analysis, Springer;German Statistical Society, vol. 106(3), pages 349-382, September.
    14. Glasgow, Simon M. & Perkins, Zane B. & Tai, Nigel R.M. & Brohi, Karim & Vasilakis, Christos, 2018. "Development of a discrete event simulation model for evaluating strategies of red blood cell provision following mass casualty events," European Journal of Operational Research, Elsevier, vol. 270(1), pages 362-374.
    15. Bogdan Batko & Paulina Rolska-Wójcik & Magdalena Władysiuk, 2019. "Indirect Costs of Rheumatoid Arthritis Depending on Type of Treatment—A Systematic Literature Review," IJERPH, MDPI, vol. 16(16), pages 1-16, August.
    16. Matteo Richiardi, 2015. "Editorial," International Journal of Microsimulation, International Microsimulation Association, vol. 8(3), pages 1-5.
    17. Alison Ritter & Nagesh Shukla & Marian Shanahan & Phuong Van Hoang & Vu Lam Cao & Pascal Perez & Michael Farrell, 2016. "Building a Microsimulation Model of Heroin Use Careers in Australia," International Journal of Microsimulation, International Microsimulation Association, vol. 9(3), pages 140-176.
    18. Filipa Aragão & José Vera & Inês Vaz Pinto, 2012. "Cost-Effectiveness of the Third-Agent Class in Treatment-Naive Human Immunodeficiency Virus-Infected Patients in Portugal," PLOS ONE, Public Library of Science, vol. 7(9), pages 1-11, September.
    19. Miguel Ortiz-Barrios & Juan-José Alfaro-Saiz, 2020. "An integrated approach for designing in-time and economically sustainable emergency care networks: A case study in the public sector," PLOS ONE, Public Library of Science, vol. 15(6), pages 1-28, June.
    20. Matthew R Behrend & María-Gloria Basáñez & Jonathan I D Hamley & Travis C Porco & Wilma A Stolk & Martin Walker & Sake J de Vlas & for the NTD Modelling Consortium, 2020. "Modelling for policy: The five principles of the Neglected Tropical Diseases Modelling Consortium," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 14(4), pages 1-17, April.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:hecrev:v:4:y:2014:i:1:p:1-16:10.1186/s13561-014-0018-2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/13561 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.